Patents by Inventor Kenji Egusa

Kenji Egusa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20230338386
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: June 30, 2023
    Publication date: October 26, 2023
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • Pharmaceutical compositions
    Patent number: 11564886
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: December 16, 2020
    Date of Patent: January 31, 2023
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Masanori Ito, Kenji Egusa, Roman Messerschmid, Peter Schneider
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20220378797
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: July 29, 2022
    Publication date: December 1, 2022
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • PHARMACEUTICAL COMPOSITION AND USES THEREOF
    Publication number: 20220287980
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: June 3, 2022
    Publication date: September 15, 2022
    Inventors: Masanori ITO, Kenji EGUSA, Kyle KLEINBECK, Roman MESSERSCHMID, Peter SCHNEIDER, Venkata VOLETI
  • PROCESS OF REWORKING
    Publication number: 20220112183
    Abstract: The invention describes a process for reworking of a crystallization product comprising drying and homogenization. The crystallization product is crystalline [5-(methylsulfonyl)-2-{[(2R)-1,1,1-trifluoropropan-2-yl]oxy}phenyl]{(1R,5R)-1-[5-(trifluoromethyl)-1,2-oxazol-3-yl]-3-azabicyclo[3.1.0]hex-3-yl}methanone. The product is dried in a tray dryer or in a pan dryer and subsequently homogenized.
    Type: Application
    Filed: October 11, 2021
    Publication date: April 14, 2022
    Inventors: Julia Regina GRIMM, Katrin BAER, Albert Josef BARTA, Gisela BODENBACH, Joe Ju GAO, Fredrik Lars NORDSTROM, Michael WIESE, Bing-Shiou YANG, Manabu NAKATANI, Masashi ADACHI, Kenji EGUSA, Roman Christian MESSERSCHMID, Daniela Maria SCHROEDER
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20210267902
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: December 16, 2020
    Publication date: September 2, 2021
    Inventors: Masanori ITO, Kenji EGUSA, Roman MESSERSCHMID, Peter SCHNEIDER
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20210196722
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: March 12, 2021
    Publication date: July 1, 2021
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
    Patent number: 10973827
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: April 13, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Friedl, Michael Braun, Kenji Egusa, Hikaru Fujita, Megumi Maruyama, Takaaki Nishioka
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20200297639
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: January 2, 2020
    Publication date: September 24, 2020
    Inventors: Masanori ITO, Kenji EGUSA, Roman MESSERSCHMID, Peter SCHNEIDER
  • Pharmaceutical composition and pharmaceutical dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
    Publication number: 20200188337
    Abstract: The present invention relates to pharmaceutical compositions comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide having the following chemical structure or a pharmaceutically acceptable salt thereof as active pharmaceutical ingredient, particularly to pharmaceutical compositions comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide hydrochloride, to pharmaceutical dosage forms, to their preparation, their use and methods for therapeutic treatment.
    Type: Application
    Filed: February 19, 2020
    Publication date: June 18, 2020
    Inventors: Kenji EGUSA, Takuma KATAYAMA, Kazutoshi YOKOYAMA, Remko Alexander BAKKER, Ngai Hang Victor CHONG, Joerg RIPPMANN
  • Pharmaceutical composition and pharmaceutical dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
    Patent number: 10603292
    Abstract: The present invention relates to pharmaceutical compositions comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide having the following chemical structure or a pharmaceutically acceptable salt thereof as active pharmaceutical ingredient, particularly to pharmaceutical compositions comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide hydrochloride, to pharmaceutical dosage forms, to their preparation, their use and methods for therapeutic treatment.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: March 31, 2020
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Kenji Egusa, Takuma Katayama, Kazutoshi Yokoyama, Remko Alexander Bakker, Ngai Hang Victor Chong, Joerg Rippmann
  • Pharmaceutical compositions
    Patent number: 10596120
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: March 24, 2020
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Masanori Ito, Kenji Egusa, Roman Messerschmid, Peter Schneider
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20200069693
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: November 7, 2019
    Publication date: March 5, 2020
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • Pharmaceutical compositions
    Patent number: 10398654
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: September 3, 2019
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Masanori Ito, Kenji Egusa, Roman Messerschmid, Peter Schneider
  • Pharmaceutical composition and pharmaceutical dosage form comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
    Publication number: 20180344672
    Abstract: The present invention relates to pharmaceutical compositions comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide having the following chemical structure or a pharmaceutically acceptable salt thereof as active pharmaceutical ingredient, particularly to pharmaceutical compositions comprising (E)-4-(2-(aminomethyl)-3-fluoroallyloxy)-N-tert-butylbenzamide hydrochloride, to pharmaceutical dosage forms, to their preparation, their use and methods for therapeutic treatment.
    Type: Application
    Filed: May 30, 2018
    Publication date: December 6, 2018
    Inventors: Kenji EGUSA, Takuma KATAYAMA, Kazutoshi YOKOYAMA, Remko Alexander BAKKER, Ngai Hang Victor CHONG, Joerg RIPPMANN
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20180289716
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 11, 2018
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
    Patent number: 10022379
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Grant
    Filed: January 11, 2017
    Date of Patent: July 17, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Friedl, Michael Braun, Kenji Egusa, Hikaru Fujita, Megumi Maruyama, Takaaki Nishioka
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20180185291
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 5, 2018
    Inventors: Masanori ITO, Kenji EGUSA, Roman MESSERSCHMID, Peter SCHNEIDER
  • DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
    Publication number: 20170119773
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and a partner drug, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: January 11, 2017
    Publication date: May 4, 2017
    Inventors: Thomas FRIEDL, Michael BRAUN, Kenji EGUSA, Hikaru FUJITA, Megumi MARUYAMA, Takaaki NISHIOKA
  • PHARMACEUTICAL COMPOSITION AND USES THEREOF
    Publication number: 20170095424
    Abstract: The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and/or a SGLT-2 inhibitor drug, and metformin XR, processes for the preparation thereof, and their use to treat certain diseases.
    Type: Application
    Filed: December 15, 2016
    Publication date: April 6, 2017
    Inventors: Masanori ITO, Kenji EGUSA, Kyle KLEINBECK, Roman MESSERSCHMID, Peter SCHNEIDER, Venkata VOLETI